Articles

Amplyx Articles

October 16, 2020PR NewswirePress Release

Amplyx to Present New Clinical and Preclinical Data for its Two Lead Programs at Upcoming Scientific Conferences

/PRNewswire/ -- Amplyx Pharmaceuticals, a clinical-stage biopharmaceutical company developing innovat... See more »
August 5, 2020PR NewswirePress Release

Amplyx Pharmaceuticals Announces Participation in Multiple Upcoming Investor Conferences

SAN DIEGO, Aug. 5, 2020 /PRNewswire/ -- Amplyx Pharmaceuticals, a clinical-stage biopharmaceutical co... See more »
July 20, 2020Endpoints NewsNews

Amplyx touts upbeat readout from a small PhII study for lead antifungal

Amplyx, a biotech focused on treating patients with compromised immune systems, is touting its lead p... See more »
July 20, 2020FE InvestegateNews

Amplyx announces positive Phase 2 data

1:28 PM: (ARIX) Amplyx announces positive Phase 2 data... See more »
June 24, 2020PR NewswirePress Release

Amplyx Pharmaceuticals to Present at the Upcoming Virtual European Biotech Investor Day 2020

SAN DIEGO, June 24, 2020 /PRNewswire/ -- Amplyx Pharmaceuticals, a clinical-stage biopharmaceutical c... See more »
June 12, 2020XconomyNews

Amplyx Pharmaceuticals added Chris LeMasters as chief operating officer

Amplyx Pharmaceuticals added Chris LeMasters as chief operating officer... See more »
May 18, 2020St Louis Post DispatchNews

San Diego biotech raises $90 million to treat infections in people with weak immune systems

SAN DIEGO - San Diego biotech company Amplyx Pharmaceuticals announced Tuesday that it has completed ... See more »
September 22, 2019San Diego Business JournalNews

Amplx Adds to Pipeline, Unveils Clinical Trial Data

Amplx Pharmaceuticals recently revealed promising data for a drug designed to treat life-threatening ... See more »
September 17, 2019XconomyNews

Amplyx Inks Novartis Deal for Another Compromised-Immune System Drug

Amplyx Pharmaceuticals, which is testing a new type of drug against life-threatening infections acqui... See more »
September 17, 2019MarketScreenerNews

Amplyx unveils expanded pipeline and reports Phase 2 data from lead programme

(marketscreener.com) Amplyx unveils expanded pipeline and reports Phase 2 data from lead programme 17... See more »
September 16, 2019The Pharma LetterNews

BRIEF-Amplyx in-licenses Ph II candidate from Novartis

US biotech firm Amplyx Pharmaceuticals has executed an exclusive worldwide license agreement with Swi... See more »
April 15, 2019XconomyNews

As Drug Resistance Grows, Amplyx Tests New Antifungal Drug

While fungal infections may seem like an annoyance rather than a serious health problem, sick people ... See more »
April 12, 2019StreetInsiderPress Release

Amplyx Pharmaceuticals Announces Presentations at the 29th ECCMID in Amsterdam

Amplyx Pharmaceuticals, a company developing first-in-class products for life-threatening infections,... See more »
February 19, 2019San Diego Business JournalNews

Amplyx Pharmaceuticals Snags FDA Orphan Drug Designation

San Diego-based Amplyx Pharmaceuticals' lead drug candidate received an orphan drug designation for a... See more »
October 10, 2017GlobeNewswirePress Release

Arix Bioscience notes positive Phase I clinical and non-clinical data from Amplyx for the treatment of life-threatening fungal infections

Arix Bioscience notes positive Phase I clinical and non-clinical data from Amplyx for the treatment o... See more »
September 22, 2017StreetInsiderPress Release

Amplyx Pharmaceuticals Announces Presentations at IDWeek 2017

Amplyx Pharmaceuticals, a biotechnology company developing novel antimicrobial agents for life-threat... See more »
July 13, 2017secPress Release

Received $40M in Equity Funding

September 25, 2016Press Release RocketPress Release

Latest Pipeline Review H2 2016 with Detail Drugs Profile

Chemotherapy Introduced Peripheral Neuropathy Pipeline Review H2 2016 'Chemotherapy Induced Periphera... See more »
September 9, 2016Business WirePress Release

Amplyx Pharma, Bakker Medical, Biosergen - Research and Markets

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Candidiasis - Pipeli... See more »
August 9, 2016NewsMakerPress Release

HIV / AIDS Treatment Pipeline Market Review H1 2016

MarketStudyReport.com adds "HIV / AIDS - Pipeline Review, H1 2016" new report to its research databas... See more »
Loading interface...
Loading interface...
Loading interface...
Loading interface...